The Lys103Asn Mutation of HIV-1 RT: A Novel Mechanism of Drug Resistance

By Hsiou Y.   Ding J.   Das K.   Clark Jr A.D.   Boyer P.L.   Lewi P.   Janssen P.A.J.   Kleim J-P.   Rösner M.   Hughes S.H.   Arnold E.  

Journal of Molecular Biology, Vol. 309, Iss. 2, 2001-06 ,pp. : 437-445

Academic Press

Access to resources Recommend Favorite

HIV-1 drug resistance: can we overcome?

By Brenner Bluma G   Wainberg Mark A   Turner Dan  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 7, 2002-10 ,pp. : 751-761

Informa Healthcare

Access to resources Recommend Favorite

New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) – The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations

By  

FEBS Open Bio, Vol. 3, Iss. 1, 2013-01 ,pp. : 144-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Borano-Nucleotides: New Analogues to Circumvent HIV-1 RT-Mediated Nucleoside Drug-Resistance

By Alvarez Karine   Deval Jérôme   Selmi Boulbaba   Barral Karine   Boretto Joelle   Guerreiro Catherine   Mulard Laurence   Sarfati Robert   Canard Bruno  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 24, Iss. 5-7, 2005-10 ,pp. : 419-422

Taylor & Francis Ltd

Access to resources Recommend Favorite

Borano-Nucleotides: New Analogues to Circumvent HIV-1 RT-Mediated Nucleoside Drug-Resistance

By Alvarez Karine   Deval Jérôme   Selmi Boulbaba   Barral Karine   Boretto Joelle   Guerreiro Catherine   Mulard Laurence   Sarfati Robert   Canard Bruno  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 24, Iss. 5-7, 2005-04 ,pp. : 419-421

Taylor & Francis Ltd

Access to resources Recommend Favorite